Literature DB >> 30139773

Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease.

Stefan Guth1,2, Christoph B Wiedenroth1,2, Andreas Rieth3,4, Manuel J Richter5, Ekkehard Gruenig6, Hossein Ardeshir Ghofrani5, Matthias Arlt7, Christoph Liebetrau3,4,8, Diethard Prüfer1, Andreas Rolf3,4,8, Christian W Hamm3,4,8, Eckhard Mayer1.   

Abstract

Symptomatic patients with chronic thromboembolic disease (CTED) without pulmonary hypertension often show an excessive increase in mean pulmonary arterial pressure (MPAP) during exercise.We report on the impact of pulmonary endarterectomy (PEA) on pulmonary haemodynamics in a prospective series of 32 consecutive CTED patients who underwent PEA. All patients had a comprehensive diagnostic work-up including right heart catheterisation at baseline and 12 months after PEA. Furthermore, in 12 patients exercise right heart catheterisation was performed before and after PEA.After PEA, MPAP was lower at rest (20±3 versus 17±3 mmHg; p=0.008) and during maximal exercise (39±8 versus 31±6 mmHg; p=0.016). The mean total pulmonary resistance (TPR) decreased from 3.6±0.8 Wood Units (WU) pre-operatively to 2.7±0.7 WU 1 year after PEA (p=0.004) and the mean slope of the MPAP/cardiac output (CO) relationship decreased from 3.6±1.0 to 2.3±0.8 WU (p=0.002). Peak oxygen uptake increased from 1.2±0.4 to 1.5±0.3 L·min-1 (p=0.014) and ventilatory equivalents of carbon dioxide decreased from 39±2 to 30±2 (p=0.002). There was a significant improvement in quality of life assessed by the Cambridge Pulmonary Hypertension Outcome Review questionnaire.In CTED patients, PEA resulted in haemodynamic and clinical improvements. The means of TPR and MPAP/CO slopes decreased to <3.0 WU.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30139773     DOI: 10.1183/13993003.00458-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  The Post-Pulmonary Embolism Syndrome: Real or Ruse?

Authors:  Steven C Pugliese; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2019-07

Review 2.  Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Krittika Teerapuncharoen; Remzi Bag
Journal:  Lung       Date:  2022-05-29       Impact factor: 2.584

3.  Pulmonary thromboendarterectomy in chronic pulmonary disease-the Royal Papworth Hospital experience.

Authors:  David P Jenkins
Journal:  Ann Cardiothorac Surg       Date:  2022-03

Review 4.  Pulmonary endarterectomy: technique and pitfalls.

Authors:  Stefan Guth; Eckhard Mayer; Diethard Prüfer; Christoph B Wiedenroth
Journal:  Ann Cardiothorac Surg       Date:  2022-03

Review 5.  Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Authors:  Yuri Matusov; Inderjit Singh; Yen-Rei Yu; Hyung J Chun; Bradley A Maron; Victor F Tapson; Michael I Lewis; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

6.  Residual Pulmonary Vascular Resistance Increase Under Left Ventricular Assist Device Support Predicts Long-Term Cardiac Function After Heart Transplantation.

Authors:  Nobutaka Kakuda; Eisuke Amiya; Masaru Hatano; Masaki Tsuji; Chie Bujo; Junichi Ishida; Hiroki Yagi; Akihito Saito; Koichi Narita; Yoshitaka Isotani; Kanna Fujita; Masahiko Ando; Shogo Shimada; Osamu Kinoshita; Minoru Ono; Issei Komuro
Journal:  Front Cardiovasc Med       Date:  2022-06-01

Review 7.  Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020.

Authors:  Michael M Madani
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

Review 8.  Chronic Thromboembolic Pulmonary Hypertension: An Update.

Authors:  Barbara Ruaro; Elisa Baratella; Gaetano Caforio; Paola Confalonieri; Barbara Wade; Cristina Marrocchio; Pietro Geri; Riccardo Pozzan; Alessia Giovanna Andrisano; Maria Assunta Cova; Maurizio Cortale; Marco Confalonieri; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2022-01-19

9.  Updates in pulmonary hypertension and other pulmonary vascular diseases.

Authors:  Roberto J Bernardo; Aleksandar Bokan; Sheila Ramjug
Journal:  Breathe (Sheff)       Date:  2019-09

Review 10.  Advances in the management of pulmonary arterial hypertension.

Authors:  Himanshu Deshwal; Tatiana Weinstein; Roxana Sulica
Journal:  J Investig Med       Date:  2021-10       Impact factor: 2.895

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.